SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040738
Filing Date
2023-11-14
Accepted
2023-11-14 06:16:05
Documents
47
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 780269
2 ex31-1.htm EX-31.1 12348
3 ex31-2.htm EX-31.2 11580
4 ex32-1.htm EX-32.1 7017
5 ex32-2.htm EX-32.2 6956
  Complete submission text file 0001493152-23-040738.txt   3825416

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ladx-20230930.xsd EX-101.SCH 25756
7 XBRL CALCULATION FILE ladx-20230930_cal.xml EX-101.CAL 34802
8 XBRL DEFINITION FILE ladx-20230930_def.xml EX-101.DEF 124472
9 XBRL LABEL FILE ladx-20230930_lab.xml EX-101.LAB 245437
10 XBRL PRESENTATION FILE ladx-20230930_pre.xml EX-101.PRE 194852
41 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 506340
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 231401414
SIC: 2836 Biological Products, (No Diagnostic Substances)